Literature DB >> 10978869

Mortality and causes of death in schizophrenia in Stockholm county, Sweden.

U Osby1, N Correia, L Brandt, A Ekbom, P Sparén.   

Abstract

A study of mortality for all patients with a first hospital diagnosis of schizophrenia in Stockholm County, Sweden, during 1973 to 1995 was performed, by linking the in-patient register with the national cause-of-death register. Overall and cause-specific standardized mortality ratios (SMR) were calculated by 5-year age classes and 5-year calendar time periods. The number of excess deaths was calculated by reducing the observed number of deaths by those expected. Our results confirmed a marked increase in mortality in schizophrenia both in males and females. Natural (somatic) causes of death was the main cause of excess deaths, with more than half of the excess deaths in females, and almost half of the excess deaths in males. Suicide was the specific cause of the largest number of excess deaths in males, while in females it was cardiovascular disease. SMRs were increased in both natural and unnatural causes of death, with 2.8 for males and 2.4 for females for all deaths, but were highest in suicide with 15.7 for males and 19.7 for females, and in unspecified violence with 11.7 for males and 9.9 for females. SMRs in suicide were especially high in young patients in the first year after the first diagnosis.

Entities:  

Mesh:

Year:  2000        PMID: 10978869     DOI: 10.1016/s0920-9964(99)00191-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  129 in total

1.  Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study.

Authors:  U Osby; N Correia; L Brandt; A Ekbom; P Sparén
Journal:  BMJ       Date:  2000 Aug 19-26

2.  Injury risk and severity in a sample of Maryland residents with serious mental illness.

Authors:  Emma E McGinty; Susan P Baker; Donald M Steinwachs; Gail Daumit
Journal:  Inj Prev       Date:  2012-06-02       Impact factor: 2.399

3.  Mortality in children and adolescents prescribed antipsychotic medication: a retrospective cohort study using the UK general practice research database.

Authors:  Fariz A Rani; Patrick Byrne; Noel Cranswick; Macey L Murray; Ian C K Wong
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

4.  A case series: evaluation of the metabolic safety of aripiprazole.

Authors:  Marc De Hert; Linda Hanssens; Ruud van Winkel; Martien Wampers; Dominique Van Eyck; Andre Scheen; Joseph Peuskens
Journal:  Schizophr Bull       Date:  2006-08-29       Impact factor: 9.306

5.  Self-harm and suicide attempts in Schizophrenia.

Authors:  Kiran Jakhar; Ram Pratap Beniwal; Triptish Bhatia; Smita N Deshpande
Journal:  Asian J Psychiatr       Date:  2017-08-18

6.  Time trends and predictors of suicide among mental health outpatients in the Department of Veterans Affairs.

Authors:  Mayur M Desai; Robert A Rosenheck; Rani A Desai
Journal:  J Behav Health Serv Res       Date:  2007-11-08       Impact factor: 1.505

7.  Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.

Authors:  Martin Strassnig; Jean Miewald; Matcheri Keshavan; Rohan Ganguli
Journal:  Schizophr Res       Date:  2007-05-02       Impact factor: 4.939

8.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

9.  Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization.

Authors:  Helena Rantanen; Anna-Maija Koivisto; Raimo K R Salokangas; Mika Helminen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-07-28       Impact factor: 4.328

Review 10.  Lipid effects of psychiatric medications.

Authors:  Junzo Watanabe; Yutaro Suzuki; Toshiyuki Someya
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.